(Q45108559)

9 December 2017

title

Suppression of pancreatic tumor growth in the liver by systemic administration of the TRAIL gene driven by the hTERT promoter (English)

1 reference

9 December 2017

Dietmar Jacob

1

1 reference

9 December 2017

John J Davis

2

1 reference

9 December 2017

Lidong Zhang

3

1 reference

9 December 2017

Hongbo Zhu

4

1 reference

9 December 2017

Fuminori Teraishi

5

1 reference

9 December 2017

Bingliang Fang

6

1 reference

9 December 2017

publication date

1 February 2005

1 reference

9 December 2017

1 reference

9 December 2017

volume

12

1 reference

9 December 2017

issue

2

1 reference

9 December 2017

page(s)

109-115

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700773

9 December 2017

exact match

0 references

cites work

Pancreatic cancer: factors regulating tumor development, maintenance and metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700773

Metastatic pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700773

Combined modality therapy for pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700773

Pancreatic cancer biology and genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700773

Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer [seecomments]

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700773

Gene therapy of pancreatic cancer with green fluorescent protein and tumor necrosis factor-related apoptosis-inducing ligand fusion gene expression driven by a human telomerase reverse transcriptase promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700773

Suppressing orthotopic pancreatic tumor growth with a fiber-modified adenovector expressing the TRAIL gene from the human telomerase reverse transcriptase promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700773

Evaluation of GAL4/TATA in vivo. Induction of transgene expression by adenovirally mediated gene codelivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700773

21 January 2018

Metastatic liver tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700773

Micrometastases from HBP malignancies and metastatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700773

Evaluation of the liver for metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700773

Combination of TRAIL gene therapy and chemotherapy enhances antitumor and antimetastasis effects in chemosensitive and chemoresistant breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700773

Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700773

Tumor necrosis factor-related apoptosis-inducing ligand and chemotherapy cooperate to induce apoptosis in mesothelioma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700773

Increased expression of death receptors 4 and 5 synergizes the apoptosis response to combined treatment with etoposide and TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700773

Adenovirus-mediated gene transfer to orthotopic hepatocellular carcinomas in athymic nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700773

"Stealth" adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700773

PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700773

Cutting edge: restoration of the ability to generate CTL in mice immune to adenovirus by delivery of virus in a collagen-based matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700773

Bilamellar cationic liposomes protect adenovectors from preexisting humoral immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700773

Treatment of advanced and metastatic pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700773

7 January 2021

An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700773

7 January 2021

Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700773

7 January 2021

Chemotherapeutic agents augment TRAIL-induced apoptosis in human hepatocellular carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700773

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700773

1 reference

Dimensions Publication ID

9 December 2017

1011115954

0 references

1 reference